Abstract 2058
Background
Identification of tumor margin during surgery is necessary for limited resection of non-small cell lung cancer (NSCLC). In this study, we developed a novel technique of lung cancer margin visualization by intraoperative inhalation of indocyanine green (ICG) and verified its clinical applicability using mouse and rabbit lung cancer model.
Methods
By observing the distribution of the inhaled ICG in each organ (lung, liver, brain, spleen, and kidneys) of mice at five different time intervals, we demonstrated that the inhaled ICG was delivered rapidly and was mainly distributed in the lung tissue. In the mouse model of lung cancer, we confirmed that the inhaled ICG entered the normal lung through phagocytosis by alveolar macrophages of normal lung tissue and rarely spread in lung cancer tissue because of mechanical airway obstruction by the tumor.
Results
Therefore, the fluorescent signal of inhaled ICG was mainly visualized in normal lung tissue but not in lung cancer tissue, which could assist in identifying the tumor margin. For clinical applicability, the inhaled dose of ICG was optimized in a rabbit lung cancer model. Compared to intravenous administration, this method accurately defined the tumor margin with 5.3-fold higher detection efficiency when 20 times lower dose of ICG was used. The ICG inhalation technique provided more clear visualization of tumor margin with lower dose and in shorter time during surgery compared to the conventional intravenous injection method.
Conclusions
The ICG inhalation technique provided more clear visualization of tumor margin with lower dose and in shorter time during surgery compared to the conventional intravenous injection method. Lung-specific delivery of the clinically approved ICG could be used effectively and safely in real clinical practice in the near future.
Clinical trial identification
Legal entity responsible for the study
Korea University.
Funding
This work was supported by a grant from the Korean Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (No: HI17C0654), and a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science, and Technology (NRF-2015R1A2A2A04005760).
Editorial Acknowledgement
This work was supported by a grant from the Korean Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (No: HI17C0654), and a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science, and Technology (NRF-2015R1A2A2A04005760).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
5877 - TCR beta chain convergence defines the tumor infiltrating T cell repertoire of melanoma and non-small cell lung carcinoma.
Presenter: Timothy Looney
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3212 - PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Presenter: Ahmad Awada
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3574 - Pan-squamous genomic profiling stratified by anatomic tumor site and viral association
Presenter: Meagan Montesion
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4113 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB)
Presenter: Han Chang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4468 - Prediction of primary resistance to anti-PD1 therapy (APD1) in 2nd line NSCLC
Presenter: Egbert Smit
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4570 - Immunomodulatory germline variation impacts the development of multiple primary melanoma (MPM).
Presenter: Robert Ferguson
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1169 - Leukocyte telomere length and recurrence risk after EGFR-TKIs therapy in patients with advanced lung adenocarcinoma
Presenter: Ming Yang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1707 - Gene embedding: a novel machine learning approach to identify gene candidates related to immunotherapy responsiveness
Presenter: Chi Tung Choy
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2123 - Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials
Presenter: Ayman Madi
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5671 - The landscape of NTRK fusions in Chinese solid tumor patients
Presenter: Qi Ling
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract